2012-10-05 16:43:41 - Recently published research from Global Markets Direct, "Peritoneal Tumor - Pipeline Review, H2 2012", is now available at Fast Market Research

Global Markets Direct's, 'Peritoneal Tumor - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Peritoneal Tumor, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Peritoneal Tumor. Peritoneal Tumor - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468437_peritoneal_tumor_pipeline_review_h2_2 ..


Note*: Certain sections in the report may be removed or altered based on the availability and

relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Peritoneal Tumor.
* A review of the Peritoneal Tumor products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Peritoneal Tumor pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Peritoneal Tumor.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Peritoneal Tumor pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Peritoneal Tumor Overview
Therapeutics Development
An Overview of Pipeline Products for Peritoneal Tumor
Peritoneal Tumor Therapeutics under Development by Companies
Peritoneal Tumor Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Peritoneal Tumor Therapeutics - Products under Development by Companies
Peritoneal Tumor Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Peritoneal Tumor Therapeutics Development
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Amgen Inc.
Sanofi-Aventis
Eli Lilly and Company
Millennium Pharmaceuticals, Inc.
Cell Therapeutics, Inc.
Bayer AG
Marshall Edwards, Inc.
MabVax Therapeutics, Inc.
CritiTech, Inc.
TRACON Pharmaceuticals, Inc.
RECEPTA Biopharma S.A.
Theradex Systems, Inc.
Peritoneal Tumor - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
trebananib - Drug Profile
enzastaurin hydrochloride - Drug Profile
sorafenib tosylate - Drug Profile
paclitaxel poliglumex - Drug Profile
ramucirumab - Drug Profile
taurolidine - Drug Profile
Vorinostat + Carboplatin + Gemcitabine - Drug Profile
imatinib mesylate - Drug Profile
Flavopiridol + Cisplatin - Drug Profile
cisplatin - Drug Profile
NSC-603071 - Drug Profile
BMS-247550 + Doxil - Drug Profile
Pazopanib + Doxil - Drug Profile
Topotecan + Iressa - Drug Profile
Avastin + Oxaliplatin + Paclitaxel - Drug Profile
Oxaliplatin + Floxuridine + Leucovorin - Drug Profile
Cytoxan + Celebrex - Drug Profile
Oxaliplatin + Topotecan - Drug Profile
Bryostatin 1 + Cisplatin - Drug Profile
Avastin + Erlotinib + Paclitaxel + Carboplatin - Drug Profile
Everolimus + Carboplatin + Pegylated Liposomal Doxorubicin - Drug Profile
sargramostim - Drug Profile
BAY 43-9006 + Paclitaxel + Carboplatin - Drug Profile
bendamustine hydrochloride - Drug Profile
Paclitaxel + Cisplatin - Drug Profile
Phenoxodiol + Carboplatin - Drug Profile
Bevacizumab + Carboplatin + Gemcitabine - Drug Profile
Carboplatin + Paclitaxel + Bevacizumab - Drug Profile
Carboplatin + Paclitaxel + Bevacizumab - Drug Profile
sunitinib malate - Drug Profile
veliparib - Drug Profile
motesanib diphosphate - Drug Profile
fenretinide - Drug Profile
Carboplatin + Ifosfamide - Drug Profile
Carboplatin + Ifosfamide + Whole Body Hyperthermia - Drug Profile
Carboplatin + Paclitaxel + Cediranib - Drug Profile
pemetrexed disodium - Drug Profile
Carboplatin + Topotecan - Drug Profile
Carboplatin + Paclitaxel - Drug Profile
WT1-Specific T Cells + Filgrastim + Cyclophosphamide + Fludarabine - Drug Profile
Bevacizumab + Carboplatin + Docetaxel + Paclitaxel - Drug Profile
Docetaxel + Trabectedin + Pegfilgrastim - Drug Profile
BAY 43-9006 + Gemcitabine - Drug Profile

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468437&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.